UPB
Upstream Bio, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 5 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Upstream Bio, Inc.
3.41
+0.14 · +4.28%
post 3.40 −0.29%
No thesis.
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $56.5M | 16.13% | +0.76% | |
| 2 | Orbimed AdvisorsOrbimed | $39.4M | 11.25% | 0.00% | |
| 3 | Norges BankNorges Bankindex-like | $26.1M | 7.45% | — | |
| 4 | BlackRockBlackRockindex-like | $26.0M | 7.42% | +11.35% | |
| 5 | Decheng CapitalDecheng Capital | $18.9M | 5.38% | 0.00% | |
| 6 | Enavate Sciences GPEnavate Sciences GP | $17.0M | 4.86% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $13.0M | 3.71% | +0.17% | |
| 8 | Millennium ManagementMillennium | $7.9M | 2.26% | +22.03% | |
| 9 | D. E. ShawD. E. Shaw | $7.2M | 2.05% | +26.27% | |
| 10 | JPMorgan ChaseJPMorgan Chase | $7.0M | 2.00% | +118.58% | |
| 11 | Qube Research & TechnologiesQube Research & Technologies | $6.8M | 1.93% | +58.00% | |
| 12 | Parkman Healthcare PartnersParkman Healthcare Partners | $6.5M | 1.85% | +18.87% | |
| 13 | Geode Capital ManagementGeodeindex-like | $6.4M | 1.84% | −2.04% | |
| 14 | SEB Asset ManagementSEB | $6.1M | 1.74% | 0.00% | |
| 15 | Woodline PartnersWoodline Partners | $5.8M | 1.64% | 0.00% | |
| 16 | State StreetState Streetindex-like | $5.3M | 1.51% | +8.64% | |
| 17 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $4.9M | 1.41% | −2.07% | |
| 18 | Y-Intercept (Hong Kong)Y-Intercept (Hong Kong) | $4.8M | 1.37% | −30.69% | |
| 19 | Bain Capital Life Sciences InvestorsBain Capital Life Sciences Investors | $4.2M | 1.19% | −30.70% | |
| 20 | AQR Capital ManagementAQR | $3.8M | 1.08% | +654.97% | |
| 21 | Morgan StanleyMorgan Stanley | $3.6M | 1.04% | −5.06% | |
| 22 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $3.5M | 1.01% | +305.99% | |
| 23 | Walleye CapitalWalleye Capital | $3.4M | 0.98% | new | |
| 24 | Trexquant InvestmentTrexquant Investment | $3.2M | 0.92% | +164.03% | |
| 25 | Point72 Asset ManagementPoint72 | $3.1M | 0.90% | +138.84% |
149 managers report $350.2M of Upstream Bio on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; FMR is largest at 16.13%.
No implied move.
No implied move.
Expected move
No implied move.